Stay Ahead in Fast-Growing Economies.

Browse Reports Now

Vernal Keratoconjunctivitis Market Current Scenario & Forecast Growth Report (2024-2032)

In Stock
$3,090
In Stock

Vernal Keratoconjunctivitis Market Size Was Valued at USD 345.10 Million in 2023, and is Projected to Reach USD 470.34 Million by 2032, Growing at a CAGR of 3.50 % From 2024-2032. Vernal Keratoconjunctivitis (VKC) is a Type 1 hypersensitivity disorder of the eye that occurs in Children and young adults thus presenting with inflammation of the cornea and conjunctiva.

Publication Date: 01/11/2025
Pages: 400
Region / Coverage: Global
In Stock
Country: Global
Product total
Options total
Grand total
Add to wishlist
IMR Group
Publisher:

IMR Group

Tag:

Description

Vernal Keratoconjunctivitis Market Synopsis:

Vernal Keratoconjunctivitis Market Size Was Valued at USD 345.10 Million in 2023, and is Projected to Reach USD 470.34 Million by 2032, Growing at a CAGR of 3.50 % From 2024-2032.

Vernal Keratoconjunctivitis (VKC) is a Type 1 hypersensitivity disorder of the eye that occurs in Children and young adults thus presenting with inflammation of the cornea and conjunctiva. The most well-known type is caused by environmental alergens and is usually found in areas with changing of the seasons. If untreated VKC can lead to severe discomfort visual disturbances and possible scarring therefore it is a condition that should be diagnosed and managed appropriately.

The Vernal Keratoconjunctivitis market is driven mainly by growing incidence of allergies and rising sensitisation regarding ocular health. Due to the increase in cases of allergic eye diseases including VKC, due to environmental pollution and increased content of allergens such as pollens and dust among others. This has led to increased need for efficient combating interventions and treatment procedures.

Also, the improved medical innovation and treatment and therapy facilities of allergic diseases act as an essential factor for this market. Thanks to the creation of new specific drugs as well as new classes of drugs, including immunotherapy, the range of solutions is increasing. These innovations accompanied by increase in accessibility of health care are escalating the need for managing VKC thereby driving the market.

Vernal Keratoconjunctivitis Market Trend Analysis:

Comprehensive treatment

There is growing tendency of immunotherapy usage in the VKC market. Since patients with chronic VKC are in search of comprehensive treatment other than conventional medicines, immunotherapy is rapidly growing popular for desensitizing the immune system and giving cure from the problem. Also, new clinical research is being attributed to employ targeted methods of treatment based on patient characteristic factors that increase the efficacy of the applied treatment.

Another trend is the perceived increased importance of Combined Therapy or compound therapies. New drugs that include both an antihistamine and a mast cell stabilizer along with corticosteroids are being used more often in order to give a holistic approach to the problem. New improved formulations and treatments regimens are anticipated to surface and continue this trend.

Scale up of awareness and diagnosis in the developing world

Probably the leading Vernal Keratoconjunctivitis market opportunity is the scale up of awareness and diagnosis in the developing world. With rising access to health care all over the world, this means that early diagnosis and thus early management of the condition can still yield better results in management. In addition, the increasing global health consciousness and access to sophisticated diagnostic equipment are other areas that offer potential for extending business to the underserved market niches.

One also notes the opportunity of the concentrations on the pediatric and adolescent population, as VKC is most common in this population. Further, the Clinicaltrials.gov search results reveal a specific need for FDA-approved recognizable age-specific treatments for this group of patients as well as topical therapies and non-invasive management options.

Vernal Keratoconjunctivitis Market Segment Analysis:

Vernal Keratoconjunctivitis Market Segmented on the basis of Type, Treatment, End-User, and Region.

By Type, Seasonal Vernal Keratoconjunctivitis segment is expected to dominate the market during the forecast period

The Vernal Keratoconjunctivitis market is segmented into two types: SVC stands for Seasonal Vernal Keratoconjunctivitis and PVC stands for Perennial Vernal Keratoconjunctivitis. SVC is marked by cathartic reactions to seasonal allergens and may manifest in spring and summer whereas PVC may last all year with onset due to indoor allergens. However, the market demand for each type is different based on the zones; SVC is mostly used in the temperate zones, whereas PVC is used in zones with high indoor allergens.

By Treatment, Medications segment expected to held the largest share

The market has several treatment options which may include Vernal Keratoconjunctivitis medication, immunotherapy, and surgery. The most utilised medications include antihistamines, mast cell stabilisers and corticosteroids. Specific immunotherapy, which implies the reduction or afferent stimulation of an immune response to allergens, is becoming increasingly popular for the treatment of respiratory allergies. In order cases, it is possible to apply surgical methods of treatment and deal with the arisen complications, including corneal opacities. Others include lubricants and other non-corticosteroids therapies are also used in managing the symptoms.

Vernal Keratoconjunctivitis Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

The market for Vernal Keratoconjunctivitis is dominated by the Asia-Pacific region primarily due to high incidence of allergies in this region. Developing countries such as India, China and Japan have a relatively high prevalence of VKC, arguably because of the climatic and environmental conditions with significant variations in seasons, and high pollen concentrations for most parts of the year. The region also receives an increased accessibility of health care which leads to the increasing availability of treatments for the population. The increasing awareness and requirement for better remedies enhance the market even more in this region.

The Asia-Pacific region is likely to remain the biggest market as the healthcare industry develops and the range of products expands. The region also offers significant growth potentialities due to high population corn and rising need for allergy specialty care.

Active Key Players in the Vernal Keratoconjunctivitis Market

AbbVie (USA)

Alcon (Switzerland)

Allergan (Ireland)

Bausch + Lomb (USA)

Lupin Pharmaceuticals (India)

Medytox (South Korea)

Novartis (Switzerland)

Pfizer (USA)

Santen Pharmaceutical Co. Ltd. (Japan)

Teva Pharmaceutical Industries Ltd. (Israel)

Other Active Players

Chapter 1: Introduction

 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Challenges

 3.2 Market Trend Analysis

 3.3 PESTLE Analysis

 3.4 Porter’s Five Forces Analysis

 3.5 Industry Value Chain Analysis

 3.6 Ecosystem

 3.7 Regulatory Landscape

 3.8 Price Trend Analysis

 3.9 Patent Analysis

 3.10 Technology Evolution

 3.11 Investment Pockets

 3.12 Import-Export Analysis

Chapter 4: Vernal Keratoconjunctivitis Market by Type

 4.1 Vernal Keratoconjunctivitis Market Snapshot and Growth Engine

 4.2 Vernal Keratoconjunctivitis Market Overview

 4.3 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  4.3.1 Introduction and Market Overview

  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)

  4.3.3 Key Market Trends, Growth Factors and Opportunities

  4.3.4 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others: Geographic Segmentation Analysis

Chapter 5: Vernal Keratoconjunctivitis Market by Application

 5.1 Vernal Keratoconjunctivitis Market Snapshot and Growth Engine

 5.2 Vernal Keratoconjunctivitis Market Overview

 5.3 Residential Commercial Industrial

  5.3.1 Introduction and Market Overview

  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)

  5.3.3 Key Market Trends, Growth Factors and Opportunities

  5.3.4 Residential Commercial Industrial: Geographic Segmentation Analysis

Chapter 6: Vernal Keratoconjunctivitis Market by End User

 6.1 Vernal Keratoconjunctivitis Market Snapshot and Growth Engine

 6.2 Vernal Keratoconjunctivitis Market Overview

 6.3 New Constructions Retrofit and Renovation

  6.3.1 Introduction and Market Overview

  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)

  6.3.3 Key Market Trends, Growth Factors and Opportunities

  6.3.4 New Constructions Retrofit and Renovation: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis

 7.1 Competitive Landscape

  7.1.1 Competitive Benchmarking

  7.1.2 Vernal Keratoconjunctivitis Market Share by Manufacturer (2023)

  7.1.3 Industry BCG Matrix

  7.1.4 Heat Map Analysis

  7.1.5 Mergers and Acquisitions  

 7.2 ALCON (SWITZERLAND)

  7.2.1 Company Overview

  7.2.2 Key Executives

  7.2.3 Company Snapshot

  7.2.4 Role of the Company in the Market

  7.2.5 Sustainability and Social Responsibility

  7.2.6 Operating Business Segments

  7.2.7 Product Portfolio

  7.2.8 Business Performance

  7.2.9 Key Strategic Moves and Recent Developments

  7.2.10 SWOT Analysis

 7.3 NOVARTIS (SWITZERLAND)

 7.4 BAUSCH + LOMB (USA)

 7.5 ALLERGAN (IRELAND)

 7.6 SANTEN PHARMACEUTICAL CO. LTD. (JAPAN)

 7.7 MEDYTOX (SOUTH KOREA)

 7.8 LUPIN PHARMACEUTICALS (INDIA)

 7.9 ABBVIE (USA)

 7.10 PFIZER (USA)

 7.11 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)

 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global Vernal Keratoconjunctivitis Market By Region

 8.1 Overview

 8.2. North America Vernal Keratoconjunctivitis Market

  8.2.1 Key Market Trends, Growth Factors and Opportunities

  8.2.2 Top Key Companies

  8.2.3 Historic and Forecasted Market Size by Segments

  8.2.4 Historic and Forecasted Market Size By Type

  8.2.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.2.5 Historic and Forecasted Market Size By Application

  8.2.5.1 Residential Commercial Industrial

  8.2.6 Historic and Forecasted Market Size By End User

  8.2.6.1 New Constructions Retrofit and Renovation

  8.2.7 Historic and Forecast Market Size by Country

  8.2.7.1 US

  8.2.7.2 Canada

  8.2.7.3 Mexico

 8.3. Eastern Europe Vernal Keratoconjunctivitis Market

  8.3.1 Key Market Trends, Growth Factors and Opportunities

  8.3.2 Top Key Companies

  8.3.3 Historic and Forecasted Market Size by Segments

  8.3.4 Historic and Forecasted Market Size By Type

  8.3.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.3.5 Historic and Forecasted Market Size By Application

  8.3.5.1 Residential Commercial Industrial

  8.3.6 Historic and Forecasted Market Size By End User

  8.3.6.1 New Constructions Retrofit and Renovation

  8.3.7 Historic and Forecast Market Size by Country

  8.3.7.1 Russia

  8.3.7.2 Bulgaria

  8.3.7.3 The Czech Republic

  8.3.7.4 Hungary

  8.3.7.5 Poland

  8.3.7.6 Romania

  8.3.7.7 Rest of Eastern Europe

 8.4. Western Europe Vernal Keratoconjunctivitis Market

  8.4.1 Key Market Trends, Growth Factors and Opportunities

  8.4.2 Top Key Companies

  8.4.3 Historic and Forecasted Market Size by Segments

  8.4.4 Historic and Forecasted Market Size By Type

  8.4.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.4.5 Historic and Forecasted Market Size By Application

  8.4.5.1 Residential Commercial Industrial

  8.4.6 Historic and Forecasted Market Size By End User

  8.4.6.1 New Constructions Retrofit and Renovation

  8.4.7 Historic and Forecast Market Size by Country

  8.4.7.1 Germany

  8.4.7.2 UK

  8.4.7.3 France

  8.4.7.4 The Netherlands

  8.4.7.5 Italy

  8.4.7.6 Spain

  8.4.7.7 Rest of Western Europe

 8.5. Asia Pacific Vernal Keratoconjunctivitis Market

  8.5.1 Key Market Trends, Growth Factors and Opportunities

  8.5.2 Top Key Companies

  8.5.3 Historic and Forecasted Market Size by Segments

  8.5.4 Historic and Forecasted Market Size By Type

  8.5.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.5.5 Historic and Forecasted Market Size By Application

  8.5.5.1 Residential Commercial Industrial

  8.5.6 Historic and Forecasted Market Size By End User

  8.5.6.1 New Constructions Retrofit and Renovation

  8.5.7 Historic and Forecast Market Size by Country

  8.5.7.1 China

  8.5.7.2 India

  8.5.7.3 Japan

  8.5.7.4 South Korea

  8.5.7.5 Malaysia

  8.5.7.6 Thailand

  8.5.7.7 Vietnam

  8.5.7.8 The Philippines

  8.5.7.9 Australia

  8.5.7.10 New Zealand

  8.5.7.11 Rest of APAC

 8.6. Middle East & Africa Vernal Keratoconjunctivitis Market

  8.6.1 Key Market Trends, Growth Factors and Opportunities

  8.6.2 Top Key Companies

  8.6.3 Historic and Forecasted Market Size by Segments

  8.6.4 Historic and Forecasted Market Size By Type

  8.6.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.6.5 Historic and Forecasted Market Size By Application

  8.6.5.1 Residential Commercial Industrial

  8.6.6 Historic and Forecasted Market Size By End User

  8.6.6.1 New Constructions Retrofit and Renovation

  8.6.7 Historic and Forecast Market Size by Country

  8.6.7.1 Turkiye

  8.6.7.2 Bahrain

  8.6.7.3 Kuwait

  8.6.7.4 Saudi Arabia

  8.6.7.5 Qatar

  8.6.7.6 UAE

  8.6.7.7 Israel

  8.6.7.8 South Africa

 8.7. South America Vernal Keratoconjunctivitis Market

  8.7.1 Key Market Trends, Growth Factors and Opportunities

  8.7.2 Top Key Companies

  8.7.3 Historic and Forecasted Market Size by Segments

  8.7.4 Historic and Forecasted Market Size By Type

  8.7.4.1 Window Air Conditioners Split Air Conditioners Portable Air Conditioners Wall Mounted Air Conditioners Centralised/Ducted Air Conditioning System Others

  8.7.5 Historic and Forecasted Market Size By Application

  8.7.5.1 Residential Commercial Industrial

  8.7.6 Historic and Forecasted Market Size By End User

  8.7.6.1 New Constructions Retrofit and Renovation

  8.7.7 Historic and Forecast Market Size by Country

  8.7.7.1 Brazil

  8.7.7.2 Argentina

  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion

9.1 Recommendations and Concluding Analysis

9.2 Potential Market Strategies

Chapter 10 Research Methodology

10.1 Research Process

10.2 Primary Research

10.3 Secondary Research

Q1: What would be the forecast period in the Vernal Keratoconjunctivitis Market research report?

A1: The forecast period in the Vernal Keratoconjunctivitis Market research report is 2024-2032.

Q2: Who are the key players in the Vernal Keratoconjunctivitis Market?

A2: Alcon (Switzerland), Novartis (Switzerland), Bausch + Lomb (USA), Allergan (Ireland), Santen Pharmaceutical Co. Ltd. (Japan), Medytox (South Korea), Lupin Pharmaceuticals (India), AbbVie (USA), Pfizer (USA), Teva Pharmaceutical Industries Ltd. (Israel) and Other Active Players.

Q3: What are the segments of the Vernal Keratoconjunctivitis Market?

A3: The Vernal Keratoconjunctivitis Market is segmented into By Type, By Treatment, By End-User and region. By Type, the market is categorized into Seasonal Vernal Keratoconjunctivitis, Perennial Vernal Keratoconjunctivitis. By Treatment, the market is categorized into Medications (Antihistamines, Mast Cell Stabilizers, Corticosteroids), Immunotherapy, Surgical Treatment, Others. By End-User, the market is categorized into Hospitals, Clinics, Ophthalmology Centers. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).

Q4: What is the Vernal Keratoconjunctivitis Market?

A4: Vernal Keratoconjunctivitis (VKC) is a Type 1 hypersensitivity disorder of the eye that occurs in Children and young adults thus presenting with inflammation of the cornea and conjunctiva. The most well-known type is caused by environmental alergens and is usually found in areas with changing of the seasons. If untreated VKC can lead to severe discomfort visual disturbances and possible scarring therefore it is a condition that should be diagnosed and managed appropriately.

Q5: How big is the Vernal Keratoconjunctivitis Market?

A5: Vernal Keratoconjunctivitis Market Size Was Valued at USD 345.10 Million in 2023, and is Projected to Reach USD 470.34 Million by 2032, Growing at a CAGR of 3.50 % From 2024-2032.

How to Buy a Report from eminsights.jp

On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.

If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.

Click the Buy Now button.

You will be redirected to the checkout page. Enter your company details and payment information.

Click Place Order to complete the purchase.

Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.

If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.

Thank you for choosing eminsights.jp!